Theseus Pharmaceuticals, Inc. (NASDAQ:THRX – Get Free Report)’s share price traded down 0.4% during trading on Tuesday . The stock traded as low as $2.27 and last traded at $2.30. 105,762 shares changed hands during trading, a decline of 68% from the average session volume of 335,687 shares. The stock had previously closed at $2.31. […]
Q3 2023 EPS Estimates for Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) Increased by Wedbush kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) Expected to Post Q1 2024 Earnings of ($0.33) Per Share modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Wedbush Reiterates "Outperform" Rating for Theseus Pharmaceuticals (NASDAQ:THRX) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Theseus Pharmaceuticals, Inc. (NASDAQ:THRX – Get Free Report) saw a large increase in short interest during the month of June. As of June 30th, there was short interest totalling 1,440,000 shares, an increase of 25.2% from the June 15th total of 1,150,000 shares. Currently, 9.5% of the company’s stock are short sold. Based on an […]